Posted on Leave a comment

Stocks Creating Buzz Look Now: VTAK, AMST, HOOK, MULN, KAVL

There are several companies that have come into focus in recent days owing to one reason or another, and it could be a prudent move to take a look at some of those. This feature would provide a closer look into some of those. On April 24, 2024, Catheter Precision Inc. (NYSE American: VTAK), a […]

Posted on Leave a comment

Cutaneous Squamous Cell Carcinoma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Incyte Crp, Merck Sharp, Regeneron Pharma, Replimune Inc

The Cutaneous Squamous Cell Carcinoma Market Forecast report offers an in-depth understanding of the Cutaneous Squamous Cell Carcinoma, historical and forecasted epidemiology as well as the Cutaneous Squamous Cell Carcinoma market trends in the 7MM. DelveInsight’s “Cutaneous Squamous Cell Carcinoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Cutaneous Squamous […]

Posted on Leave a comment

Axillary Hyperhidrosis Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH

The Axillary Hyperhidrosis Market Forecast report offers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology as well as the Axillary Hyperhidrosis market trends in the 7MM. DelveInsight’s “Axillary Hyperhidrosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Axillary Hyperhidrosis, historical and forecasted epidemiology as well as the […]

Posted on Leave a comment

Invasive Aspergillosis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2023-2032), States DelveInsight | Pulmocide, F2G Biotech GmbH, Scynexis, Biosergen, CSPC Ouyi

The Invasive Aspergillosis Market Forecast report offers an in-depth understanding of the Invasive Aspergillosis, historical and forecasted epidemiology as well as the Invasive Aspergillosis market trends in the 7MM. DelveInsight’s “Invasive Aspergillosis Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Invasive Aspergillosis, historical and forecasted epidemiology as well as the […]

Posted on Leave a comment

CD BioSciences Introduces Multicolor Immunofluorescence Staining Kits for Enhanced Research

CD BioSciences launches new Multicolor Immunofluorescence Staining Kits for researchers. CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to announce the launch of its new Multicolor Immunofluorescence Staining Kits. These kits empower researchers to achieve high-quality staining of tissues and cells utilizing 2-7 different colors, enabling more detailed […]

Posted on Leave a comment

Celiac Disease Pipeline Analysis 2024: Clinical Trials, FDA Approvals, Emerging Therapies, ROA, MOA and Treatment Outlook by DelveInsight | Amgen, AMYRA Biotec, Equillium Bio, Chugai Pharmaceutical

Celiac Disease Pipeline As per DelveInsight’s assessment, globally, Celiac Disease pipeline constitutes 25+ key companies continuously working towards developing 25+ Celiac Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. (New York, United States) “Celiac Disease Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present […]

Posted on Leave a comment

Diabetic Kidney Disease Market is anticipated to Grow at a CAGR of ~6.5% by 2034, analyzes DelveInsight | Boehringer Ingelheim, Daiichi Sankyo, ProKidney, Chinook Therapeutics, AbbVie,Inversago Pharma

Diabetic Kidney Disease Market The dynamics of the diabetic kidney disease market are anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of emerging therapies (Albany, USA) DelveInsight’s Diabetic Kidney Disease Market Insights report includes a comprehensive understanding of […]

Posted on Leave a comment

Rheumatoid Arthritis Pipeline Assessment 2024: Clinical Trials, FDA, EMA, and PMDA Approvals, Therapies, Treatment Market, Growth Prospects, and Companies by DelveInsight

Rheumatoid Arthritis pipeline Rheumatoid Arthritis pipeline report including 120+ key companies and 120+ Rheumatoid Arthritis treatment therapies, analyses DelveInsight (Albany, USA) “Rheumatoid Arthritis Pipeline Insight 2024” report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Rheumatoid Arthritis Market.  The Rheumatoid Arthritis Pipeline report embraces in-depth commercial and […]

Posted on Leave a comment

Peripheral T-cell Lymphoma Market Forecast 2032: Clinical Trials, Epidemiology Trends, FDA Approvals, Companies & Growth Analysis Report by DelveInsight

Peripheral T-cell Lymphoma Market Peripheral T-cell Lymphoma companies are Eisai, Celgene Corporation, HUYA Bioscience International/Quintiles, Verastem, BeiGene, Merck Sharp & Dohme Corp, Solasia Pharma, Aileron Therapeutics, Incyte, Novartis, and others. (Albany, USA) DelveInsight’s “Peripheral T-cell Lymphoma Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Peripheral T-cell Lymphoma, historical and forecasted epidemiology […]

Posted on Leave a comment

Cutaneous T-Cell Lymphoma (CTCL) Market Size was USD 520 million in 2023, estimates DelveInsight | 4SC, Bio-Path Holdings, BioInvent International, Bioniz Therapeutics, Citius Pharmaceuticals, Roche

Cutaneous T-Cell Lymphoma Market Cutaneous T-Cell Lymphoma (CTCL) Companies are 4SC, Bio-Path Holdings, BioInvent International AB, Bioniz Therapeutics, Citius Pharmaceuticals, Codiak BioSciences, Elorac, Equillium, Genzada Pharmaceuticals, Hoffmann-La Roche, Innate Pharma, Jiangsu Simcere Pharmaceutical, Kymera Therapeutics, Legend Biotech, Merck Sharp & Dohme LLC, miRagen Therapeutics, Myeloid Therapeutics, Otsuka Pharmaceutical, Scopus BioPharma, Soligenix, Sorrento Therapeutics, VidacPharma, Viridian […]